Vendor, Cambridge, MA
Emerald Innovations, Inc.
UEI MDE4D4W9J7H3, CAGE 8AVC5
1 award and $0 obligated between June 13, 2025 and May 19, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40124C00013Definitive Contract, June 13, 2025, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Modification Is to Change the Contracting Officer'S Representative (Cor) from Mark Lauda to Darby Kozak.NAICS 541714, PSC B504 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- B504 Chemical/Biological Studies and Analysis
- Transactions
- 3 across 1 awards